Evidence map›Paper›PMID 41571709›Full record

ArticleNature communications2026

Additive-specific modulation of non-classical nucleation pathways.

Annet Baken, Alejandro Fernandez-Martinez, Martine Lanson, Xavier M Aretxabaleta, Hegoi Manzano, Matthias Kellermeier, Marco Di Michiel, Alexander E S Van Driessche

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Annet BakenESRF, European Synchotron Radiation Facility, ID15a Materials Science Beamline, Grenoble, France.
Alejandro Fernandez-MartinezUniv. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, IRD, IFSTTAR ISTerre, Grenoble, France.ORCID http://orcid.org/0000-0001-5073-9629
Martine LansonUniv. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, IRD, IFSTTAR ISTerre, Grenoble, France.
Xavier M AretxabaletaDepartment of Physics, Faculty of Science and Technology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.ORCID http://orcid.org/0000-0003-4107-3698
Hegoi ManzanoDepartment of Physics, Faculty of Science and Technology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.ORCID http://orcid.org/0000-0001-7992-2718
Matthias KellermeierBASF SE, Material Science, RGA/BM-B007, Ludwigshafen am Rhein, Germany.
Marco Di MichielESRF, European Synchotron Radiation Facility, ID15a Materials Science Beamline, Grenoble, France.
Alexander E S Van DriesscheInstitutoAndaluz de Ciencias de la Tierra (CSIC), Armilla, Granada, Spain. alexander.vd@csic.es.ORCID http://orcid.org/0000-0003-2528-3425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Additives, comprising small quantities of organic and inorganic molecules, are crucial for controlling the crystallisation of various (bio)materials; however, their mechanisms remain poorly understood. By integrating in situ high-energy X-ray scattering with potentiometric titrations, we examine the impact of industrially relevant additives on the nucleation pathways of portlandite and gypsum. While both minerals undergo multistep nucleation, portlandite transitions gradually from a disordered to an ordered phase, whereas gypsum exhibits an abrupt transition. These distinct non-classical pathways and their pH conditions correlate with the mineral-specific effects of the additives. Additive effects extend beyond the classical models, such as cation-binding, exerting influence primarily during the prenucleation stage. Moreover, additives demonstrate a dual role by simultaneously delaying and accelerating different stages of nucleation, highlighting their multifaceted impact on the crystallisation process. These findings offer insights for designing tailored additives to optimise industrial crystallisation processes and advance the understanding of biomineralisation mechanisms.

Identifiers

PMID41571709
PMCPMC12923757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.